Volume 30, Number 10—October 2024
Dispatch
Autochthonous Human Babesia divergens Infection, England
Table
Days after admission | % Parasitemia† | Intervention |
---|---|---|
0 | 18 | IV quinine, 10 mg/kg every 8 h; IV clindamycin, 600 mg every 6 h |
1 |
9 |
|
2 |
2.4 |
IV quinine, 10 mg/kg every 8 h; IV clindamycin, 600 mg every 6 h; nasogastric atovaquone, 750 mg every 12 h |
3 | 1.3 | 4 units red blood cells via manual exchange transfusion |
4 |
0.9 |
|
5 | 0.07 | IV azithromycin, 250 mg every 24 h; IV clindamycin, 600 mg every 6 h; nasogastric atovaquone 750 mg every 12 h |
6 | 0.1 | |
7 |
0.08 |
|
8 | 0.05 | IV doxycycline, 200 mg every 24 h |
9 | 0.03 | |
10 |
0.03 |
|
11 | 0.02 | 2 units of M- and S-antigen–negative red blood cells |
12 | 0.01 | |
13 | 0.01 | |
14 |
0 |
|
15 | 0 | Antiparasitic agents discontinued |
*IV, intravenous. †Percentage of parasitized erythrocytes detected by light microscopy of thin blood films.
Page created: August 28, 2024
Page updated: September 23, 2024
Page reviewed: September 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.